Author

Ana Garre 1

1 Hospital Universitario de La Princesa, IIS-IP and CIBERehd,Madrid,Spain

CLINICAL DIFFERENTIAL CHARACTERISTICS OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) OF ONSET IN PEDIATRIC AGE COMPARED TO PATIENTS DIAGNOSED IN ADULTHOOD

Maria Chaparro Sanchez, Ana Garre, Elena Ricart, Valle García-Sánchez, Carlos Taxonera, Miriam Mañosa, Isabel Vera Mendoza, Miguel Mínguez, Federico Argüelles, Luisa de Castro, M Arroyo, Antonio López-Sanromán, Montserrat Rivero Tirado, Jordi Guardiola Capon, María Dolores Martín-Arranz, Belen Beltran, Jesús Barrio, Sabino

Efficacy in second-line regimens in Spain: results from the European Registry on H. pylori management (Hp-EuReg)

María Caldas Álvarez, Maria Angeles Perez Aisa, Manuel Castro Fernández, Luis Bujanda, Alfredo J. Lucendo, Jennifer Hinojosa, Nuria Fernandez Moreno, Luis Ricardo Rodrigo Sáez, Manuel Pabon, Luis Ferrer Barceló, Horacio Alonso Galán, Jorge Pérez Lasala, Javier Molina Infante, Benito Velayos, Jesús Barrio, Angel Lanas, Manue

Efficacy of first-line regimens in Spain: results from the European Registry on H. pylori management (Hp-EuReg)

María Caldas Álvarez, Mari Ángeles Perez Aisa, Manuel Castro Fernández, Luis Bujanda, Alfredo J. Lucendo, Nuria Fernandez Moreno, Jennifer Hinojosa, Luis Ricardo Rodrigo Sáez, Teresa Romero García, Luis Ferrer Barceló, Horacio Alonso Galán, Jorge Pérez Lasala, Javier Molina Infante, Luis Fernández Salazar, Jesús Barrio Andrés

Epidemiology, clinical characteristics, evolution and treatments in newly diagnosed inflammatory bowel disease (IBD): results from the nationwide EpidemIBD study of GETECCU

Maria Chaparro Sanchez, Manuel Barreiro-de Acosta, Jose Manuel Benitez, Jose Luis Cabriada, María José Casanova, Daniel Ceballos, María Esteve, Hipólito Fernández, Daniel Ginard, Fernando Gomollón, Rufo H. Lorente, Pilar Nos, Sabino Riestra, Montserrat Rivero, Pilar Robledo, Cristina Rodriguez, Beatriz Sicilia, Emilio Torr

EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB FOR THE INDUCTION OF REMISSION IN INFLAMMATORY BOWEL DISEASE PATIENTS

Maria Chaparro Sanchez, M Sierra-Ausin, Francisco Mesonero, Ana Belen Beltran Niclos, Nuria Maroto Arce, Ruth De Francisco Garcia, Miguel Mínguez, Y González-Lama, Manuel Barreiro de Acosta, IGNACIO MARIN, Valle García, David Busquets Casals, Alfredo J. Lucendo, Santiago García, Fernando Bermejo, Ramón Pajares Villarroya, B

EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASES

Maria Chaparro Sanchez, Ana Garre, Elena Ricart, Marisa Iborra, Francisco Mesonero Gismero, Maria Vera, Sabino Riestra Menéndez, V García-Sánchez, Luisa de Castro, A Martin-Cardona, Xavier Aldeguer, M Mínguez, Manuel Barreiro de-Acosta, Montserrat Rivero, F Muñoz, Montserrat Andreu, A Bargallo, E García-Planella, J. L. Pé

RISK FACTORS ASSOCIATED WITH THE NEGATIVIZATION OF ANTI-HBS ANTIBODIES IN INFLAMMATORY BOWEL DISEASE PATIENTS

Alicia C. Marin, Maria Chaparro Sanchez, Mercedes Ramas, Ana Garre, Pablo M. Linares, José Villagrasa, David Bernardo, Javier Gisbert

Item 1 - 7 / 7
1